4 Reasons NeoStem May See Significant Share Price Appreciation
NeoStem (NASDAQ:NBS) offers investors an excellent opportunity to realize significant share price appreciation over the next several months and beyond. NeoStem has quickly become one of the leaders in the cellular therapy industry. Cellular therapy describes the process of introducing new cells into a tissue to prevent or treat a disease, or regenerate damaged or aged tissue, and consists of a separate therapeutic technology platform.
The company’s platform includes the development of novel cell therapy products as well as operating a contract development and manufacturing organization. Cellular therapy is one of the hottest niches within the healthcare sector and should give rise to a bright future for companies involved.
The 4 most important reasons why NeoStem offers an attractive investment opportunity are: Diversified Product Candidate Portfolio, Share Price Potential on AMR-001 Approval, Recent Decision for NASDAQ Listing, and Financial Health.